|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hennessy BT, Coleman RL and Markman M:
Ovarian cancer. Lancet. 374:1371–1382. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vergote I, Tropé CG, Amant F, Kristensen
GB, Ehlen T, Johnson N, Verheijen RH, van der Burg ME, Lacave AJ,
Panici PB, et al; European Organization for Research and Treatment
of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group.
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV
ovarian cancer. N Engl J Med. 363:943–953. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jayson GC, Kohn EC, Kitchener HC and
Ledermann JA: Ovarian cancer. Lancet. 384:1376–1388. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baldi A, Ioannis P, Chiara P, Eleonora F,
Roubini C and Vittorio D: Biological effects of milk proteins and
their peptides with emphasis on those related to the
gastrointestinal ecosystem. J Dairy Res. 72(S1): 66–72. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Walhout AJ, Sordella R, Lu X, Hartley JL,
Temple GF, Brasch MA, Thierry-Mieg N and Vidal M: Protein
interaction mapping in C. elegans using proteins involved in vulval
development. Science. 287:116–122. 2000. View Article : Google Scholar
|
|
7
|
Zhou J, Chen J, Mokotoff M and Ball ED:
Targeting gastrin-releasing peptide receptors for cancer treatment.
Anticancer Drugs. 15:921–927. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mader JS and Hoskin DW: Cationic
antimicrobial peptides as novel cytotoxic agents for cancer
treatment. Expert Opin Investig Drugs. 15:933–946. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang W, Gu F, Wei C, Tang Y, Zheng X, Ren
M and Qin Y: PGPIPN, a therapeutic hexapeptide, suppressed human
ovarian cancer growth by targeting BCL2. PLoS One. 8:e607012013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fiat AM, Migliore-Samour D, Jollès P,
Drouet L, Bal dit Sollier C and Caen J: Biologically active
peptides from milk proteins with emphasis on two examples
concerning antithrombotic and immunomodulating activities. J Dairy
Sci. 76:301–310. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ganjam LS, Thornton WH Jr, Marshall RT and
MacDonald RS: Antiproliferative effects of yogurt fractions
obtained by membrane dialysis on cultured mammalian intestinal
cells. J Dairy Sci. 80:2325–2329. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kayser H and Meisel H: Stimulation of
human peripheral blood lymphocytes by bioactive peptides derived
from bovine milk proteins. FEBS Lett. 383:18–20. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meisel H: Biochemical properties of
regulatory peptides derived from milk proteins. Biopolymers.
43:119–128. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meisel H and FitzGerald RJ: Biofunctional
peptides from milk proteins: Mineral binding and cytomodulatory
effects. Curr Pharm Des. 9:1289–1295. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Green MR and Sambrook J: Molecular
Cloning: A Laboratory Manual. 4th edition. Cold Spring Habor
Laboratory Press; New York, NY: 2012
|
|
17
|
Chi JY, Hsiao YW, Li CF, Lo YC, Lin ZY,
Hong JY, Liu YM, Han X, Wang SM, Chen BK, et al: Targeting
chemotherapy-induced PTX3 in tumor stroma to prevent the
progression of drug-resistant cancers. Oncotarget. 6:23987–24001.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shan D, Li J, Cai P, Prasad P, Liu F,
Rauth AM and Wu XY: RGD-conjugated solid lipid nanoparticles
inhibit adhesion and invasion of αvβ3 integrin-overexpressing
breast cancer cells. Drug Deliv Transl Res. 5:15–26. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen HY, Mollstedt O, Tsai MH and Kreider
RB: Potential clinical applications of multi-functional milk
proteins and peptides in cancer management. Curr Med Chem.
21:2424–2437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nongonierma AB and FitzGerald RJ:
Bioactive properties of milk proteins in humans: A review.
Peptides. 73:20–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bonuccelli G, Castello-Cros R, Capozza F,
Martinez-Outschoorn UE, Lin Z, Tsirigos A, Xuanmao J,
Whitaker-Menezes D, Howell A, Lisanti MP, et al: The milk protein
α-casein functions as a tumor suppressor via activation of STAT1
signaling, effectively preventing breast cancer tumor growth and
metastasis. Cell Cycle. 11:3972–3982. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Terasaki-Fukuzawa Y, Kijima H, Suto A,
Takeshita T, Iezumi K, Sato S, Yoshida H, Sato T, Shimbori M and
Shiina Y: Decreased nm23 expression, but not Ki-67 labeling index,
is significantly correlated with lymph node metastasis of breast
invasive ductal carcinoma. Int J Mol Med. 9:25–29. 2002.
|
|
23
|
Pencil SD, Toh Y and Nicolson GL:
Candidate metastasis-associated genes of the rat 13762NF mammary
adenocarcinoma. Breast Cancer Res Treat. 25:165–174. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Toh Y, Pencil SD and Nicolson GL: A novel
candidate metastasis-associated gene, mta1, differentially
expressed in highly metastatic mammary adenocarcinoma cell lines.
cDNA cloning, expression, and protein analyses. J Biol Chem.
269:22958–22963. 1994.PubMed/NCBI
|
|
25
|
Toh Y, Pencil SD and Nicolson GL: Analysis
of the complete sequence of the novel metastasis-associated
candidate gene, mta1, differentially expressed in mammary
adenocarcinoma and breast cancer cell lines. Gene. 159:97–104.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Toh Y, Oki E, Oda S, Tokunaga E, Ohno S,
Maehara Y, Nicolson GL and Sugimachi K: Overexpression of the MTA1
gene in gastrointestinal carcinomas: Correlation with invasion and
metastasis. Int J Cancer. 74:459–463. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Futamura M, Nishimori H, Shiratsuchi T,
Saji S, Nakamura Y and Tokino T: Molecular cloning, mapping, and
characterization of a novel human gene, MTA1-L1, showing homology
to a metastasis-associated gene, MTA1. J Hum Genet. 44:52–56. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu H, Mao H and Fu X: Expression of nm23
in breast cancer: Correlation with distant metastasis and
prognosis. Zhonghua Zhong Liu Za Zhi. 23:224–227. 2001.(In
Chinese).
|
|
29
|
Huang G, Song Y and He G: mRNA expression
and mutation of MTA1 and nm23H1 genes in ovarian carcinoma in
relation to lymph node metastasis. Zhonghua Zhong Liu Za Zhi.
23:31–34. 2001.(In Chinese).
|
|
30
|
Kreider RB, Iosia M, Cooke M, Hudson G,
Rasmussen C, Chen H, Mollstedt O and Tsai MH: Bioactive properties
and clinical safety of a novel milk protein peptide. Nutr J.
10:992011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fiedorowicz E, Jarmołowska B, Iwan M,
Kostyra E, Obuchowicz R and Obuchowicz M: The influence of μ-opioid
receptor agonist and antagonist peptides on peripheral blood
mononuclear cells (PBMCs). Peptides. 32:707–712. 2011. View Article : Google Scholar
|
